PharmaResearch Co., Ltd. (KOSDAQ:214450)

South Korea · Delayed Price · Currency is KRW

313,500

-8,500 (-2.64%)

Apr 30, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	536.29B	350.12B	261.01B	194.76B	154.08B
Pharmaceuticals Growth	53.18%	34.14%	34.02%	26.40%	41.69%
Total	536.29B	350.12B	261.01B	194.76B	154.08B
Total Growth	53.18%	34.14%	34.02%	26.40%	41.69%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Overseas	207.50B	130.37B	90.94B	56.10B	42.49B
Overseas Growth	59.16%	43.36%	62.09%	32.05%	69.24%
South Korea	328.79B	219.75B	170.07B	138.65B	111.60B
South Korea Growth	49.62%	29.21%	22.66%	24.25%	33.42%
Total	536.29B	350.12B	261.01B	194.76B	154.08B
Total Growth	53.18%	34.14%	34.02%	26.40%	41.69%

Source: S&P Global Market Intelligence.